Therapeutic efficacy of upadacitinib in refractory juvenile idiopathic arthritis: a case report - Top-Institutions - MDSpire

Therapeutic efficacy of upadacitinib in refractory juvenile idiopathic arthritis: a case report

  • By

  • Ningning Li

  • Hao Zhang

  • Bingbing Dai

  • July 10, 2026

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Cincinnati Children’s Hospital Medical Center
    Cincinnati Children’s Hospital Medical Center

    Cincinnati, Ohio

    Key Differentiators

    • Rheumatology
    • Pediatrics

  • #2

    Boston Children’s Hospital
    Boston Children’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Rheumatology
    • Pediatrics

Original Source(s)

Therapeutic efficacy of upadacitinib in refractory juvenile idiopathic arthritis: a case report

  • by Ningning Li, Hao Zhang, Bingbing Dai

  • July 10, 2026

Related Content

Development and validation of subtype-specific simplified ultrasound assessment systems for juvenile idiopathic arthritis: a prospective observational study

Circular RNA circNUP214 serves as a microRNA-31 sponge to promote the progression of myasthenia gravis through NFAT5

Integrated pain management in a child with arthritis in Cape Verde: a case report